Medicine - Table of Contents

January 5, 2022

Salivary miRNAs as non-invasive biomarkers of hepatocellular carcinoma: a pilot study

Arshiya Mariam, Galen Miller-Atkins, Amika Moro, Alejandro I. Rodarte, Shirin Siddiqi, Lou-Anne Acevedo-Moreno, J. Mark Brown, Daniela S. Allende, Federico Aucejo, Daniel M. Rotroff

https://doi.org/10.7717/peerj.12715 PubMed 35036096

January 18, 2022

Bioinformatics analysis and identification of hub genes and immune-related molecular mechanisms in chronic myeloid leukemia

Fangyi Yao, Cui Zhao, Fangmin Zhong, Tingyu Qin, Shuqi Li, Jing Liu, Bo Huang, Xiaozhong Wang

https://doi.org/10.7717/peerj.12616 PubMed 35111390

January 25, 2022

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer

Yichi Zhang, Yifeng Lin, Daojun Lv, Xiangkun Wu, Wenjie Li, Xueqing Wang, Dongmei Jiang

https://doi.org/10.7717/peerj.12843 PubMed 35127296

January 5, 2022

A critical review on modulators of Multidrug Resistance Protein 1 in cancer cells

Vivian Osei Poku, Surtaj Hussain Iram

https://doi.org/10.7717/peerj.12594 PubMed 35036084

January 18, 2022

Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis

Mengyuan Zhang, Zhike Zhou, Zhouyang Liu, Fangxi Liu, Chuansheng Zhao

https://doi.org/10.7717/peerj.12768 PubMed 35111402

January 4, 2022

Key genes associated with prognosis and metastasis of clear cell renal cell carcinoma

Tingting Zhong, Zeying Jiang, Xiangdong Wang, Honglei Wang, Meiyi Song, Wenfang Chen, Shicong Yang

https://doi.org/10.7717/peerj.12493 PubMed 35036081

January 4, 2022

Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma

Yun Gao, Ziyi Dai, Chenxi Yang, Ding Wang, Zhenying Guo, Weimin Mao, Zhongjian Chen

https://doi.org/10.7717/peerj.12568 PubMed 35036082

January 5, 2022

Identification of FEZ2 as a potential oncogene in pancreatic ductal adenocarcinoma

Chaozhi Yang, Xuebing Wang, Chenjie Qiu, Ziruo Zheng, Kai Lin, Min Tu, Kai Zhang, Kuirong Jiang, Wentao Gao

https://doi.org/10.7717/peerj.12736 PubMed 35036176

January 3, 2022

Role of miR-100-5p and CDC25A in breast carcinoma cells

Xiaoping Li, Yanli Ren, Donghong Liu, Xi Yu, Keda Chen

https://doi.org/10.7717/peerj.12263 PubMed 35036112

January 26, 2022

miR-148a-3p inhibits the proliferation and migration of bladder cancer via regulating the expression of ROCK-1

Chao Xu, Guanwen Zhou, Zhuang Sun, Zhaocun Zhang, Haifeng Zhao, Xianzhou Jiang

https://doi.org/10.7717/peerj.12724 PubMed 35127282

January 18, 2022

Functional genetic variants in complement component 7 confer susceptibility to gastric cancer

Siyue Wang, Wenqian Hu, Yuning Xie, Hongjiao Wu, Zhenxian Jia, Zhi Zhang, Xuemei Zhang

https://doi.org/10.7717/peerj.12816 PubMed 35111412

January 5, 2022

Cancer types with high numbers of driver events are largely preventable

Aleksey V. Belikov, Sergey V. Leonov

https://doi.org/10.7717/peerj.12672 PubMed 35036090

January 21, 2022

Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma

Yucang Shi, Zhanpeng Li, Zhihong Zhou, Simu Liao, Zhiyuan Wu, Jie Li, Jiasheng Yin, Meng Wang, Meilan Weng

https://doi.org/10.7717/peerj.12646 PubMed 35116193

January 2022

Table of Contents - PeerJ (Medicine Articles)

January 2022

Table of Contents - PeerJ (Medicine Articles)

Archives - Medicine

Filter on subjects this month